Cite
Lubas MM, Mandrell BN, Greene WL, et al. A randomized double-blind placebo-controlled trial of the effectiveness of melatonin on neurocognition and sleep in survivors of childhood cancer. Pediatr Blood Cancer. 2021;69(1):e29393doi: 10.1002/pbc.29393.
Lubas, M. M., Mandrell, B. N., Greene, W. L., Howell, C. R., Christensen, R., Kimberg, C. I., Li, C., Ness, K. K., Srivastava, D. K., Hudson, M. M., Robison, L. L., Krull, K. R., & Brinkman, T. M. (2022). A randomized double-blind placebo-controlled trial of the effectiveness of melatonin on neurocognition and sleep in survivors of childhood cancer. Pediatric blood & cancer, 69(1), e29393. https://doi.org/10.1002/pbc.29393
Lubas, Margaret M, et al. "A randomized double-blind placebo-controlled trial of the effectiveness of melatonin on neurocognition and sleep in survivors of childhood cancer." Pediatric blood & cancer vol. 69,1 (2022): e29393. doi: https://doi.org/10.1002/pbc.29393
Lubas MM, Mandrell BN, Greene WL, Howell CR, Christensen R, Kimberg CI, Li C, Ness KK, Srivastava DK, Hudson MM, Robison LL, Krull KR, Brinkman TM. A randomized double-blind placebo-controlled trial of the effectiveness of melatonin on neurocognition and sleep in survivors of childhood cancer. Pediatr Blood Cancer. 2022 Jan;69(1):e29393. doi: 10.1002/pbc.29393. Epub 2021 Oct 21. PMID: 34674368.
Copy
Download .nbib